Nama Insights

First Trust NYSE Arca Biotechnology Index Fund (FBT)

Health · First Trust · NYSE

HealthETF
First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund in the Health category. It has $2.91B in assets, an expense ratio of 0.55% and a 0.00% dividend yield. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Assets under management$2.91B
Expense ratio0.55%
CategoryHealth
Dividend yield0.00%
NAV$268.05
Fund familyFirst Trust
ExchangeNYSE

Top holdings

The largest positions First Trust NYSE Arca Biotechnology Index Fund reports, by weight.

HoldingNameWeight
HALO Halozyme Therapeutics Inc 4.34%
NEO NeoGenomics Inc 3.94%
RGEN Repligen Corp 3.90%
CORT Corcept Therapeutics Inc 3.83%
ONC BeOne Medicines Ltd ADR 3.74%
REGN Regeneron Pharmaceuticals Inc 3.74%
NTRA Natera Inc 3.70%
AMGN Amgen Inc 3.67%
ARGX argenx SE ADR 3.65%
GMAB Genmab AS ADR 3.55%

Other Health ETFs

Explore live FBT data on Nama Insights →